T-cell acute lymphoblastic leukemia | Blood Cancers Today

T-cell acute lymphoblastic leukemia

FDA Grants Fast Track, Rare Pediatric Disease Designations to WU-CART-007 for T-ALL, ALL

Leah SherwoodTransplantation & Cellular Therapy | November 16, 2022

The FDA has granted Fast Track Designation and Rare Pediatric Disease Designation for WU-CART-007.

First Dose of Off-the-Shelf CAR T Given to Patients with R/R T-ALL/LBL

Leah LawrenceT-Cell Lymphoma | April 4, 2022

WU-CART-007 is being tested as part of a phase 1/2 trial to evaluate if off-the-shelf therapy is safe and feasible.

Advertisement

Advertisement

Advertisement

Advertisement